ASLAN A4 Series: Aspects of Atopic Dermatitis and ASLAN004 (eblasakimab)
ASLAN’s A4 webinar series: ‘Dialogues with International Thought Leaders in Dermatology’ featured a series of Key Opinion Leader (KOL) events on the emerging Atopic Dermatitis (AD) landscape and ASLAN004 (eblasakimab)
-
Jonathan Silverberg, MD PhD MPH
Heterogeneity in ADAssociate Professor of Dermatology
George Washington University School of Medicine and Health Sciences
Episode 1: 25 Oct 2021
Accompanying slides, A4 KOL Series: Episode 1, Jonathan Silverberg -
April Armstrong, MD MPH
A closer look: Key factors impacting responses in AD clinical trialsProfessor of Dermatology and Associate Dean
University of Southern California
Episode 2: 20 Jan 2022
Accompanying slides, A4 KOL Series: Episode 2, April Armstrong -
Peter Lio, MD
AD: Patient journeys and unmet needsClinical Assistant Professor of Dermatology and Pediatrics,
Northwestern University Fienberg School of Medicine
Episode 3: 22 June 2022
Accompanying slides, A4 KOL Series: Episode 3, Peter Lio
